BridgeBio Pharma

BBIONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$16.533 B

$84.48 +2.03%

Close of 7 Aug 2026

Revenue

$502.1M

#1908 by revenue

Earnings

—

Not reported

Shares outstanding

195,861,242

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#24ViatrisVTRS$19.1B
#25Jazz PharmaceuticalsJAZZ$16.7B
#26BridgeBio PharmaBBIO$16.5B
#27Ascendis Pharma A/SASND$15.8B
#28Arrowhead PharmaceuticalsARWR$12.4B

Where these numbers come from

Share counts and financials for BridgeBio Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.